Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam M Klein

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Archives of Otolaryngology--Head & Neck Surgery|April 20, 2011
Association of asthma with clinically aggressive recurrent respiratory papillomatosisPhilip K Robb, Paul M Weinberger, Helen Perakis, et al.
Head & Neck|April 29, 2025
Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-UpPauline Kim, Nabil F Saba, Ashley McCook-Veal, et al.
The Laryngoscope|February 23, 2023
Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory PapillomatosisSamir A Ballestas, Julio Hidalgo Lopez, Adam M Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomyJonathan J Beitler, Susan Muller, William J Grist, et al.
The Laryngoscope|July 20, 2023
Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary InvolvementRaymond J So, Julio C Hidalgo Lopez, Samir A Ballestas, et al.
The Laryngoscope|May 19, 2023
Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory PapillomatosisTed Mau, Milan R Amin, Peter C Belafsky, et al.
The Laryngoscope|August 3, 2024
A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory PapillomatosisSimon R Best, Jonathan M Bock, Nicole B Fowler, et al.
The Laryngoscope|August 9, 2025
DNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRPMilan R Amin, Peter C Belafsky, Simon R Best, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and NeckDong M Shin, Sreenivas Nannapaneni, Mihir R Patel, et al.
The Laryngoscope|January 16, 2026
Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRPSimon R Best, Aaron D Friedman, Clark A Rosen, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Archives of Otolaryngology--Head & Neck Surgery|April 20, 2011
Association of asthma with clinically aggressive recurrent respiratory papillomatosisPhilip K Robb, Paul M Weinberger, Helen Perakis, et al.
Head & Neck|April 29, 2025
Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-UpPauline Kim, Nabil F Saba, Ashley McCook-Veal, et al.
The Laryngoscope|February 23, 2023
Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory PapillomatosisSamir A Ballestas, Julio Hidalgo Lopez, Adam M Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomyJonathan J Beitler, Susan Muller, William J Grist, et al.
The Laryngoscope|July 20, 2023
Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary InvolvementRaymond J So, Julio C Hidalgo Lopez, Samir A Ballestas, et al.
The Laryngoscope|May 19, 2023
Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory PapillomatosisTed Mau, Milan R Amin, Peter C Belafsky, et al.
The Laryngoscope|August 3, 2024
A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory PapillomatosisSimon R Best, Jonathan M Bock, Nicole B Fowler, et al.
The Laryngoscope|August 9, 2025
DNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRPMilan R Amin, Peter C Belafsky, Simon R Best, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and NeckDong M Shin, Sreenivas Nannapaneni, Mihir R Patel, et al.
The Laryngoscope|January 16, 2026
Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRPSimon R Best, Aaron D Friedman, Clark A Rosen, et al.
Pageof 7